TABLE OF CONTENTS
Volume 12, Issue 1 (January 2005)
Original Articles
Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells
Se-Hee Son, Eunsil Yu, Eun Kyung Choi, Heuiran Lee and Jene Choi
Cancer Gene Ther 12: 1-11; advance online publication, November 5, 2004; doi:10.1038/sj.cgt.7700755
In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer
Sunil Sudarshan, David H Holman, Marc L Hyer, Christina Voelkel-Johnson, Jian-Yun Dong and James S Norris
Cancer Gene Ther 12: 12-18; advance online publication, October 29, 2004; doi:10.1038/sj.cgt.7700746
Tumor-specific intravenous gene delivery using oncolytic adenoviruses
Jinghui Zhan, Yi Gao, Wensheng Wang, Annie Shen, Amy Aspelund, Mandy Young, Sylvie Laquerre, Leonard Post and Yuqiao Shen
Cancer Gene Ther 12: 19-25; advance online publication, October 29, 2004; doi:10.1038/sj.cgt.7700730
Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor
Gandham Mahendra, Sanjay Kumar, Tatyana Isayeva, Parameshwar J Mahasreshti, David T Curiel, Cecil R Stockardt, William E Grizzle, Vidya Alapati, Raj Singh, Gene P Siegal, Sreelatha Meleth and Selvarangan Ponnazhagan
Cancer Gene Ther 12: 26-34; advance online publication, October 8, 2004; doi:10.1038/sj.cgt.7700754
Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors
Xueying Sun, Haiquan Qiao, Hongchi Jiang, Xuting Zhi, Fengjun Liu, Jianli Wang, Meng Liu, Dianning Dong, Jagat R Kanwar, Ruian Xu and Geoffrey W Krissansen
Cancer Gene Ther 12: 35-45; advance online publication, October 15, 2004; doi:10.1038/sj.cgt.7700766
Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy
Loren W Noblitt, Dinesh S Bangari, Shruti Shukla, Sulma Mohammed and Suresh K Mittal
Cancer Gene Ther 12: 46-53; advance online publication, October 15, 2004; doi:10.1038/sj.cgt.7700763
Growth hormone releasing hormone plasmid supplementation, a potential treatment for cancer cachexia, does not increase tumor growth in nude mice
Amir S Khan, Louis C Smith, Ingrid W Anscombe, Kathleen K Cummings, Melissa A Pope and Ruxandra Draghia-Akli
Cancer Gene Ther 12: 54-60; advance online publication, September 17, 2004; doi:10.1038/sj.cgt.7700767
ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis
Chae-Ok Yun, Eunhee Kim, Taeyoung Koo, Hoguen Kim, Young-sook Lee and Joo-Hang Kim
Cancer Gene Ther 12: 61-71; advance online publication, September 17, 2004; doi:10.1038/sj.cgt.7700769
Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12
Naoki Okada, Sayaka Iiyama, Yuka Okada, Hiroyuki Mizuguchi, Takao Hayakawa, Shinsaku Nakagawa, Tadanori Mayumi, Takuya Fujita and Akira Yamamoto
Cancer Gene Ther 12: 72-83; advance online publication, September 24, 2004; doi:10.1038/sj.cgt.7700772
CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo
Natalia Lapteva, An-Gang Yang, Denise E Sanders, Randall W Strube and Si-Yi Chen
Cancer Gene Ther 12: 84-89; advance online publication, October 8, 2004; doi:10.1038/sj.cgt.7700770
Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer
Mark A Rochester, Johann Riedemann, Giles O Hellawell, Simon F Brewster and Valentine M Macaulay
Cancer Gene Ther 12: 90-100; advance online publication, October 22, 2004; doi:10.1038/sj.cgt.7700775
Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK
Surren A Soghomonyan, Michael Doubrovin, Jeremy Pike, Xiang Luo, Martina Ittensohn, Jacob D Runyan, Julius Balatoni, Ronald Finn, Juri Gelovani Tjuvajev, Ronald Blasberg and David Bermudes
Cancer Gene Ther 12: 101-108; advance online publication, October 22, 2004; doi:10.1038/sj.cgt.7700779
